Content RevOps for Life Sciences

    Content marketing and demand generation for pharma, biotech, medtech, CDMO, CRO, and diagnostics companies. Built for technical buyers, long sales cycles, and buying committees. Run as one connected system from first search to closed revenue.

    Market reality

    What life sciences marketing looks like right now

    0%

    of pharma and biotech websites show no meaningful content marketing.

    0%

    of life science industry queries now trigger an AI answer. Corporate sites are cited in almost none of them.

    0%

    of life science sites publish case studies. Fewer than 1 in 20 show pricing.

    0.00/4

    Average industry score for distribution. It is the single weakest link between good content and pipeline.

    What this means

    This is the real opportunity. Not generic ad campaigns, but a structured marketing program built for the scientific field.

    Why generic playbooks fail

    Digital marketing for life sciences has four realities most agencies do not plan for

    6 to 7 content touches

    Technical buyers verify every claim

    Scientists, clinicians, and engineers do not accept marketing language at face value. They read papers, compare specs, and check citations before a call is booked. Generic top of funnel content bounces because it has no evidence, no depth, and nothing to verify.

    2 to 6 week review cycles

    Regulated content and MLR review

    Every claim runs through medical, legal, and regulatory review. That is a feature of the industry, not a bug. Programs that ignore this ship irregular, one off assets. Programs that plan around it produce steady, compounding output.

    4 to 7 stakeholders per deal

    Committee buying, not individual buying

    A scientist finds you. Procurement, QA, IT, and a VP all weigh in. Content has to speak to each seat at the table with the evidence they need to defend the choice internally. Single audience content stalls at the internal sell.

    12 to 24 months

    12 to 24 month sales cycles

    Budget cycles, validation, and pilots stretch decisions across quarters. Campaigns that are measured in weeks look like failures. Systems that stay in front of the buyer for the whole cycle look like the obvious choice by the time procurement engages.

    So what actually works

    One connected system, not five disconnected campaigns

    Most life science marketing spend goes into pieces that do not talk to each other. Content lives on the site, distribution lives on LinkedIn, CRM lives with sales, and nothing gets measured back to revenue. We run it as one loop.

    1. 1

      Research and positioning

      ICP, buying committee, and evidence requirements mapped before writing anything.

    2. 2

      Content engine

      Articles, thought leadership, and webinars built for technical readers and MLR review.

    3. 3

      Distribution

      Search, AI answers, LinkedIn, and email placed where your buyers actually research.

    4. 4

      Capture and routing

      CRM handoff, lead scoring, and sales enablement wired into the same system.

    5. 5

      Measurement

      Content attributed back to pipeline and revenue, then fed to the next research cycle.

    By sub vertical

    How we approach different areas of life science marketing

    Each area has a different buyer, a different objection, and a different content job. Here is what we actually build in each.

    The problem

    MLR review slows output. HCP and patient audiences need separate lanes with separate rules. Paid channels are restricted, so organic presence carries more weight here than in almost any other industry. Most of your competitors have given up on it: about 1 in 17 pharma sites runs a blog at all.

    What we build

    • Claim libraries and pre-approved content templates agreed with your medical, legal, and regulatory team, so review gets faster with every piece instead of slower
    • Indication and mechanism explainers written to the evidence standard, with citations built in at the draft stage
    • Congress and KOL material repurposed into digital assets: session summaries, speaker Q&As, poster walkthroughs
    • Separate HCP and patient content lanes, each with its own review path and disclaimers

    How it reaches buyers

    Search and AI answers for indication, mechanism, and category queries. LinkedIn for the commercial and medical affairs audience. Email nurture sequenced to the buying committee, not blasted to a list.

    What we wire up

    CRM tracking on every asset, lead scoring, and routing that separates medical affairs interest from commercial interest. Fewer than 9 percent of pharma companies run a CRM at all, which is why leads go cold. Yours will not.

    Data pointNear zero pharma sites are cited in AI answers for decision-stage queries

    The problem

    One website has to serve investors, pharma BD teams, potential partners, and future customers at the same time, often before revenue. The platform is technical, the story is early, and credibility is the entire game.

    What we build

    • Platform positioning: a narrative that a non-specialist board member and a specialist reviewer can both follow and repeat
    • Publication driven thought leadership: your papers, posters, and preprints turned into readable explainers, founder bylines, and LinkedIn material
    • A resource hub that doubles as due diligence material: the questions a BD team or investor will ask, answered in public before the data room
    • Ghostwriting for scientific founders, so the people with the credibility are the ones who are visible

    How it reaches buyers

    Search and AI answers for platform and modality queries. LinkedIn from founder and company accounts. Content bursts timed to your conference presentations and publications.

    What we wire up

    Intent capture on the resource hub, so you know which firms and companies are reading your due diligence material, with enriched alerts routed to BD.

    Data pointAbout 90 percent of pharma and biotech websites show no meaningful content marketing

    The problem

    Three different readers with three different questions. Clinicians want clinical evidence. The value analysis committee wants economics and workflow impact. Procurement wants comparisons and a pricing signal. Most device sites answer none of the three in public, so sales answers them one meeting at a time.

    What we build

    • Clinical evidence pages: outcomes data, study summaries, and citation-backed claims in a format a clinician can skim between cases
    • Value analysis committee assets: cost impact, workflow impact, and training burden, published as pages and as PDFs your reps can send
    • Comparison content: honest, criteria-based comparisons that sales can share during the internal review instead of losing the deal silently
    • ROI and cost calculators. Almost no life science company publishes one, and procurement committees use them directly.

    How it reaches buyers

    Search for procedure and category terms. AI answers for comparison and cost questions. Sales enablement distribution through your reps into the committee.

    What we wire up

    Account-level visibility into which hospitals and systems touched evidence and comparison content, surfaced to sales before and during the committee stage.

    Data pointFewer than 1 in 100 life science sites publish an ROI calculator

    The problem

    Sponsors shortlist on limited public information, and the RFP is often decided before the first call. If your capabilities, capacity, and quality story are not findable and specific, you are not on the list, and you never find out why.

    What we build

    • Capability content with real specificity: modalities, scales, equipment, tech transfer process, and realistic timelines
    • Therapeutic area and modality depth pages, so a sponsor searching their exact problem lands on your exact answer
    • Technical explainers and process content that demonstrate quality thinking instead of claiming it
    • Webinars built around a speaker who is both a respected peer and a current customer, the highest-trust format in this space

    How it reaches buyers

    Search and AI answers for capability queries. LinkedIn for BD contacts and sponsor program managers. Distribution timed around the industry events where sponsors are actively comparing.

    What we wire up

    Account-level intent, so you see which sponsor domains are reading which capability pages, routed to BD weekly.

    Data pointAbout 95 percent of pharma keywords are top of funnel. Commercial intent terms are nearly uncontested

    The problem

    Labs, health systems, and clinicians each need different proof. Reimbursement, workflow fit, and clinical utility all have to be answered in public, or your sales team answers them one meeting at a time and your cycle stretches.

    What we build

    • Clinical utility content: what the test changes about a care decision, backed by literature
    • Reimbursement resources: coverage, coding, and billing pages kept current. They are among the most searched and least published content in the category.
    • Workflow integration explainers: instrument fit, LIS integration, staffing impact, and validation support
    • Benchmark and calculator assets that let a lab quantify the case internally before they ever talk to you

    How it reaches buyers

    Search and AI answers for test category and reimbursement queries. Targeted LinkedIn for lab directors and health system roles. Email nurture segmented by buyer type, because a lab director and an administrator need different proof.

    What we wire up

    Buyer-stage tagging, so the lab director reading validation content and the administrator reading reimbursement content each get the right follow-up automatically.

    Data pointDistribution is the weakest content dimension in life sciences: 1.72 out of 4

    Services we offer to life science companies

    What are you trying to get done?

    Same services other agencies list. Different arrangement, and connected to each other on purpose.

    Content marketing and demand generation

    Get found by the right buyers

    SEO built for technical and regulated queries. Editorial planning around buying committee questions. Demand programs that turn attention into pipeline, not just traffic.

    Answer engine optimization

    Be the answer when AI answers for you

    Structured, citable content that surfaces in ChatGPT, Perplexity, and Google AI Overviews for indication, product, and category queries. Delivered inside the content program.

    Thought leadership

    Build authority the market takes seriously

    Founder and executive positioning built on original research, publication grade content, and points of view that make BD, partnering, and investor conversations easier.

    Sales enablement content

    Give your sales team something to send

    Technical explainers, comparison pages, and evidence packs that reduce the education load on reps and speed internal buy in across clinical, procurement, and exec review.

    Webinar marketing

    Turn webinars into pipeline

    Webinar production run as a demand system. Two Westlab webinars sourced pipeline that outperformed months of cold outreach. We handle topic, speakers, production, promotion, and follow up.

    Marketing automation

    Keep leads from going cold

    Nurture built for 12 to 24 month cycles. CRM integration and sales alerts on intent, not just form fills. The layer that keeps content producing pipeline months after publish.

    Proof

    Westlab: 241 inbound leads in 3 months

    A life science laboratory equipment manufacturer that had grown through trade shows, cold outreach, and distributors. We rebuilt their go to market around a content led system built for how life science buyers actually research.

    Westlab
    Life Sciences
    Content Marketing
    Webinars
    Lead Generation

    Prospect education turned into inbound demand

    A resource hub positioned as the reference for lab equipment procurement. Technical comparison guides mapped to real buying questions. Two webinars that outperformed months of cold outreach. CRM workflows that surfaced intent to sales before the first call.

    0

    inbound leads in 3 months

    $0k

    in influenced quotes

    0%

    ROI on the program

    0%

    increase in organic traffic

    0

    educational pieces in 2 months

    0

    webinars that sourced pipeline

    "We wanted an inbound generating machine. Stefan and Content RevOps delivered."

    Nathan Price

    Nathan Price

    VP Client Relations, Westlab Canada

    Life sciences resource hub

    Life science marketing resources you won't find anywhere else

    Reports, benchmarks, infographics, articles, and case studies.

    Reports

    2 items

    Infographics

    4 items

    Articles

    3 items

    Tools and case studies

    2 items

    Browse the full Life Sciences resource library

    Benchmark yourself

    Already do life science marketing? See how you stack up against 2,000 industry players.

    Answer 12 short questions and get a live score, tier and top fixes — the same tool we use in strategy calls.

    Benchmark your marketing against 2,000 life science companies

    —/100
    0/12 answered
    Awaiting input
    01

    Publishing cadence

    How many insights, technical briefs, clinical updates or thought-leadership pieces have you published in the last 12 months?

    02

    Buyer proof on site

    How many case studies, named customer outcomes or peer-reviewed validations live on your website?

    03

    Contextual CTAs

    Roughly what % of your insight / content pages offer a next step tied to what the reader just read?

    04

    Resource hub

    Do you have a structured resource / insights hub with topic categorisation (not a date-ordered news feed)?

    05

    Decision-stage assets

    Tick the ones live on your site today.

    06

    Marketing investment

    How many dedicated marketing or content hires have you made in the last 12 months?

    07

    Inbound pipeline share

    Roughly what % of your pipeline / qualified meetings are sourced from inbound or content (not outbound, RFP, KOL or events)?

    08

    Non-branded keyword footprint

    Roughly how many non-branded keywords does your site rank for on Google? (Free check: Semrush or Ahrefs — exclude your firm name)

    09

    Monthly organic traffic

    Roughly how many monthly visitors does your site get from Google?

    10

    Active marketing channels

    Which channels are you actively running right now?

    11

    Content formats in play

    Which content formats do you actively produce?

    12

    Annual marketing spend

    Roughly what's your total annual marketing budget? (USD, all-in: people, agencies, ads, congresses, tools)

    Your live scorecard

    Answer the 12 questions to see where you sit against ~2,000 life sciences firms.

    FAQ

    Questions life science growth leaders usually ask

    Real answers, not sales copy.

    Life science buyers are technical, skeptical, and buy in committees. They read papers, verify claims, and expect evidence. Sales cycles run 12 to 24 months and involve regulatory, clinical, procurement, and executive review. Generic B2B playbooks that assume a single decision maker, quick close, and unregulated claims break on contact with this environment. Life science marketing has to speak to multiple readers, respect MLR review, and stay in front of buyers long enough to matter.

    First inbound signals usually appear inside the first 60 to 90 days when content is built for the buying committee and distributed properly. Pipeline that closes takes longer because the sales cycle is longer. What compounds first is qualified inbound volume and reduced sales education load. Revenue attribution catches up as deals started in the first quarter close through the year.

    It is one of the few things that does. A long cycle means the buyer is researching for a long time. If you are absent during that research, you are absent from the shortlist. Content built as a system, rather than as campaigns, stays present across quarters and gives sales a reason to re engage without cold follow up.

    We plan for review from the start. That means evidence led claims, source citations built into drafts, and internal review cycles built into the calendar rather than bolted on after production. We work with your medical, legal, and regulatory teams on templates and pre approved language so review speeds up over time. The result is steady output that clears review, not backlogs of unpublishable drafts.

    Answer engine optimization is the practice of structuring content so it can be cited by AI answer engines like ChatGPT, Perplexity, and Google AI Overviews. In life sciences, 100 percent of industry queries now trigger an AI answer, and most corporate sites are not cited. That is a visibility problem the same size as search was ten years ago. AEO is how you become the source the AI quotes when your buyer asks about your indication, product, or category.

    Programs typically run in the mid five figures per month at the smaller end and scale from there based on output, distribution, and sales integration. Cost is driven by content volume, therapeutic complexity, review requirements, and how much of the CRM and sales enablement layer we run. We share honest ranges on a first call once we understand scope.

    Every piece is tracked in the CRM against the accounts and deals it touches. We report inbound lead volume, qualified pipeline sourced and influenced, sales cycle length, and cost per opportunity, not just traffic and impressions. Revenue attribution respects the reality of long, multi touch cycles rather than assigning credit to a single last touch.

    Yes. Pre revenue biotechs have a different job to do with content, which is credibility and positioning for BD conversations, partnerships, and future customers. We build platform positioning, publication driven thought leadership, and a resource hub that doubles as due diligence material. The output supports fundraising, partnering, and the commercial team you will hire later.

    Ready when you are

    Marketing built for how life sciences actually buy

    Book a call and we will walk through your current program, where it is leaking, and what a Content RevOps system would look like in your sub vertical.